Breast Cancer Segment, by Application to Account Largest Share in Electronic Patient-Reported Outcomes (ePROS) Market during 2023-2031

According to our new research study on "Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Global Analysis - by Delivery Mode, Application, End User, and Geography," the market was valued at US$ 843.77 million in 2023 and is projected to reach US$ 2,868.00 million by 2031; it is expected to register a CAGR of 16.5% during 2023-2031. The practice of outsourcing clinical studies with a massive rise in the number of trials and the flourishing pharmaceutical industry with a surge in research and development activities are contributing to the electronic patient-reported outcomes (ePROS) market growth. However, the data privacy and security issues hamper market growth. Further, the integration of artificial intelligence and machine learning with ePROS platforms is expected to bring new electronic patient-reported outcomes (ePROS) market trends in the coming years.

EPRO platforms integrate artificial intelligence (AI) and machine learning (ML) to improve data analysis and predictive analytics. Using these technologies, patterns in patient-reported data can be found, allowing for more individualized treatment plans and early detection of possible health problems. Deeper insights are also obtained by analyzing patient free-text responses using AI-driven natural language processing (NLP). For example, Medable, the digital health platform, and Clario integrate AI with their ePRO solutions to improve patient involvement, data accuracy, and real-time insights in clinical trials. These technological advancements are transforming ePRO systems, making them more efficient, accessible, and a major part of the digital health ecosystem. In August 2023, the next-generation, cutting-edge software platform from assisTek, a Pennsylvania-based Clinical Technology company, was intended to streamline their current eCOA (electronic Clinical Outcome Assessments) and ePRO (electronic Patient-Reported Outcomes) solutions. This state-of-the-art platform incorporates new features and upgrades, such as a proprietary custom operating system, AI-powered configurator, remote device provisioning for improved reusability, and single sign-on (SSO). Thus, the integration of artificial intelligence and machine learning with ePROS platforms, which offers new capabilities to enhance patient data collection, analysis, and integration, is expected to bring new trends in the electronic patient-reported outcomes (ePROS) market in the coming years.

The electronic patient-reported outcomes (ePROS) market, based on delivery mode, is divided into cloud-based and on-premise. The cloud-based segment held a larger electronic patient-reported outcomes (ePROS) market share in 2023; however, the on-premise segment is expected to register a higher CAGR during 2023-2031. Cloud-based ePRO systems allow providers to record patients' opinions about their health conditions, treatments, and quality of life, which is essential given the increasing focus on patient-centered healthcare. Large-scale patient data processing and analysis capabilities are increasingly needed in cloud-based ePRO systems owing to the growing use of AI, machine learning, and data analytics in healthcare. In addition, cloud-based ePRO systems allow decentralized trials to collect data more effectively, especially in remote areas, eliminating the need for patients to visit clinical sites. For example, Varian Medical Systems, Inc. offers a cloud-based mobile service-the Noona platform-intended to record PROs in oncology. By utilizing electronic patient-reported outcomes (ePROs) and oncology-specific questionnaires for remote symptom management, Noona provides enhanced capabilities compared to a typical patient portal. In addition to improving patient outcomes, the collection and tracking of ePROs facilitates effective communication and propels cancer research. Because of these advantages, cloud-based ePRO is being adopted more quickly across the healthcare industry, fueling the segment's growth.

Based on Application, the market is segmented into oncology, respiratory, and others. The oncology segment held the largest electronic patient-reported outcomes (ePROS) market share in 2023, and it is estimated to register the highest CAGR during 2023-2031. Electronic patient-reported outcome (ePRO) assessment can be valuable in palliative oncology settings, supporting clinicians' and patients' clinical activities. The benefits of ePRO systems, including enhanced quality of life and care, real-time monitoring, and efficient communication, were consistent with the increasing form of research highlighting the advantages of using technology in cancer treatment. This system has the potential to address the different issues in cancer care. For instance, in July 2024, a research team at the University of California, Irvine, created and executed an intervention to improve cancer care support services for patients who belong to racial and ethnic minorities and are undergoing chemotherapy. Using the web-based electronic patient-reported outcome tool, people can enter their health information into a computer, tablet, or smartphone. The ePRO and digital analytics were used in this study and were available in several languages. Thus, this innovative strategy plays a crucial role in addressing the ongoing health disparities that racial and ethnic minorities experience in cancer care. Further, monitoring electronic patient-reported outcomes (ePRO) has gained traction as a potential way to improve cancer patient care and surveillance over the last ten years.

OpenClinica LLC, Buddy Healthcare Ltd Oy, Castor, Medable Inc, Assistek, Signant Health, Crucial Data Solutions, Curebase, Y-Prime LLC, Clinical Ink Inc, Medidata Solutions, Veeva Systems Inc, Medrio, and PatientIQ are among the leading companies operating in the global electronic patient-reported outcomes (ePROS) market.

Companies operating in the electronic patient-reported outcomes (ePROS) market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the electronic patient-reported outcomes (ePROS) market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall electronic patient-reported outcomes (ePROS) market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com